Cigna

Basketball billionaire enters the no-insurance, no-middleman drug business

BY: - February 2, 2022

Mark Cuban, owner of the Dallas Mavericks, is getting into a business pioneered by independent pharmacists in Ohio and elsewhere. The idea is to radically reduce consumer costs for common generic drugs by cutting out insurance companies and the middlemen they hire to handle transactions with manufacturers and pharmacies. On Jan. 19, the Mark Cuban […]

Ohio suits against drug middlemen headed for the long haul

BY: - June 7, 2021

Ohio has been one of the most active states litigating against drug middlemen, whom Attorney General Dave Yost accuses of bilking state agencies out of tens of millions of dollars. Other states also have been active in court against the healthcare giants. Notably, Arkansas last year squared off at the U.S. Supreme Court against the […]

Federal regulator’s oversight of the drug supply chain blasted — by one of the regulators

BY: - June 4, 2021

One of two federal agencies tasked with policing anticompetitive behavior among corporations last week said it has a lot more work to do when it comes to the prescription-drug supply chain. One of the members of the Federal Trade Commission went even further. He suggested the agency has abdicated its responsibility as drug prices have […]

Antitrust concerns are increasing on Capitol Hill. Advocates say they should extend to drug pricing

BY: - June 1, 2021

Antitrust concerns are increasing on Capitol Hill. Advocates say they should extend to drug pricing.

Federal probe of drug middlemen urged

BY: - May 10, 2021

After years of accusations in Ohio and elsewhere, a bipartisan group in the U.S. Senate wants federal regulators to investigate whether drug middlemen and their parent companies are rigging the system to raise prices and pad their pockets. Sens. Chuck Grassley, R-Iowa, and Maria Cantwell, D-Wash., last month filed legislation that would require the federal […]